|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/198 | |
| A61K 31/195 | |||
| A61K 31/275 | |||
| A61K 31/138 | |||
| A61K 31/345 | |||
| A61K 45/06 |
| (11) | Number of the document | 2167066 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08769311.5 |
| Date of filing the European patent application | 2008-05-07 | |
| (97) | Date of publication of the European application | 2010-03-31 |
| (45) | Date of publication and mention of the grant of the patent | 2013-06-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/062879 |
| Date | 2008-05-07 |
| (87) | Number | WO 2008/137923 |
| Date | 2008-11-13 |
| (30) | Number | Date | Country code |
| 916497 P | 2007-05-07 | US |
| (72) |
ROBERTS, Michael, J., US
PEDDER, Simon, US
|
| (73) |
Chelsea Therapeutics, Inc.,
3530 Toringdon Way Suite 200, Charlotte, NC 28277,
US
|
| (54) | DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF ATTENTION DEFICIT DISORDERS |
| DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF ATTENTION DEFICIT DISORDERS |